HK1099228A1 - Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis - Google Patents

Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Info

Publication number
HK1099228A1
HK1099228A1 HK07106587.9A HK07106587A HK1099228A1 HK 1099228 A1 HK1099228 A1 HK 1099228A1 HK 07106587 A HK07106587 A HK 07106587A HK 1099228 A1 HK1099228 A1 HK 1099228A1
Authority
HK
Hong Kong
Prior art keywords
adefovir
tenofovir
breast cancer
mmtv
biliary cirrhosis
Prior art date
Application number
HK07106587.9A
Other languages
English (en)
Inventor
Cihlar Tomas
Janet L Douglas
Craig S Gibbs
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1099228A1 publication Critical patent/HK1099228A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK07106587.9A 2004-01-21 2007-06-20 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis HK1099228A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (1)

Publication Number Publication Date
HK1099228A1 true HK1099228A1 (en) 2007-08-10

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106587.9A HK1099228A1 (en) 2004-01-21 2007-06-20 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Country Status (11)

Country Link
US (2) US20070281911A1 (xx)
EP (1) EP1732569B1 (xx)
JP (1) JP2007518815A (xx)
AT (1) ATE445404T1 (xx)
AU (1) AU2005209256B2 (xx)
CA (1) CA2553455A1 (xx)
DE (1) DE602005017131D1 (xx)
ES (1) ES2334149T3 (xx)
HK (1) HK1099228A1 (xx)
NZ (1) NZ548532A (xx)
WO (1) WO2005072748A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006239677A1 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
PT2020996E (pt) 2006-05-16 2012-02-20 Gilead Sciences Inc Método e composições para tratar neoplasias malignas hematológicas
ES2681839T3 (es) * 2009-10-05 2018-09-17 Ambergen Inc. Un procedimiento para diagnosticar cirrosis biliar primaria (CBP) usando nuevos autoantígenos
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
CA3131037A1 (en) 2011-11-30 2013-06-06 Emory University Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
RS62434B1 (sr) 2014-12-26 2021-11-30 Univ Emory Antivirusni n4-hidroksicitidin derivati
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
CN111372592A (zh) 2017-12-07 2020-07-03 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
JPWO2020171225A1 (ja) * 2019-02-22 2021-12-16 一素 村田 ｍＴＯＲ阻害剤
US12029783B2 (en) 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine
EP3993873A4 (en) * 2019-07-02 2023-09-20 Virago Vax Inc. SUPPRESSION OF BREAST TUMORS
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5314700A (en) * 1999-06-01 2000-12-18 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
ATE399204T1 (de) * 1999-06-30 2008-07-15 Univ Tulane Humanes endogenes retrovirus
AU2001282941C1 (en) * 2000-07-21 2016-12-22 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
JP4476811B2 (ja) * 2002-05-13 2010-06-09 メタバシス・セラピューティクス・インコーポレイテッド Ｐｍｅａおよびそのアナログの新規ホスホン酸系プロドラッグ

Also Published As

Publication number Publication date
ES2334149T3 (es) 2010-03-05
US20050239753A1 (en) 2005-10-27
EP1732569A1 (en) 2006-12-20
US20070281911A1 (en) 2007-12-06
AU2005209256A1 (en) 2005-08-11
NZ548532A (en) 2009-09-25
AU2005209256B2 (en) 2010-11-18
EP1732569B1 (en) 2009-10-14
WO2005072748A1 (en) 2005-08-11
ATE445404T1 (de) 2009-10-15
CA2553455A1 (en) 2005-08-11
DE602005017131D1 (de) 2009-11-26
JP2007518815A (ja) 2007-07-12

Similar Documents

Publication Publication Date Title
HK1099228A1 (en) Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
PH12020551244A1 (en) Pd-1/pd-l1 inhibitors
IL169881A0 (en) Adhesive patches for the transdermal delivery of granisetron
TW200745078A (en) Isoindole-imide compounds and compositions comprising and methods of using the same
MX2010003355A (es) Derivados de quinazolinona 6-,7-, u 8-sustituidos y composiciones que los comprenden y metodos para usar los mismos.
BRPI0515319A (pt) análogos de quinolona
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
IL176142A0 (en) Processes for preparing montelukast sodium
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
TW200731991A (en) Lipophilic di(anticancer drug) compounds, compositions and related methods
TW200731974A (en) Transdermal system for verenicline
ZA200709481B (en) Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
SG155939A1 (en) Phosphoindoles as hiv inhibitors
WO2007120333A3 (en) Tetracyclic kinase inhibitors
PL2079446T3 (pl) Preparat paliperidonu o przedłużonym uwalnianiu
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
PL1865931T3 (pl) Plaster przezskórny
TW200638932A (en) CCI-779 polymorph and use thereof
PH12019502290A1 (en) Therapeutic agent for blood cancer
MX2007004461A (es) Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.
DK1635843T3 (da) Terapi, der omfatter dienogest for hormonerstatning og depression
UA88325C2 (xx) Фосфоіндоли як інгібітори віл[фосфоиндолы как ингибиторы вич
TW200621740A (en) Compound for treating hepatitis B and composition thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140121